NO20054775L - Biaryl-substituerte triazoler som natriumkanalblokkere - Google Patents

Biaryl-substituerte triazoler som natriumkanalblokkere

Info

Publication number: NO20054775L
Authority: NO; Norway
Prior art keywords: compounds; pain; alone; pharmaceutically acceptable; effective amount
Prior art date: 2003-03-18

Application number

NO20054775A

Other languages

English (en)

Norwegian (no)

Other versions

NO20054775D0 (no

Inventor

Prasun K Chakravarty

Williams H Parsons

Michael H Fisher

Brenda Palucki

Min K Park

Bishan Zhou

James P Carey

Douglas E Frantz

Michael H Kress

Damian Weaver

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-18

Filing date

2005-10-17

Publication date

2005-12-16

2005-10-17 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

2005-10-17 Publication of NO20054775D0 publication Critical patent/NO20054775D0/no

2005-12-16 Publication of NO20054775L publication Critical patent/NO20054775L/no

Links

239000003195 sodium channel blocking agent Substances 0.000 title 1
150000003852 triazoles Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 7
238000000034 method Methods 0.000 abstract 3
208000002193 Pain Diseases 0.000 abstract 2
239000003937 drug carrier Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
208000019901 Anxiety disease Diseases 0.000 abstract 1
208000020925 Bipolar disease Diseases 0.000 abstract 1
208000000094 Chronic Pain Diseases 0.000 abstract 1
206010065390 Inflammatory pain Diseases 0.000 abstract 1
108010052164 Sodium Channels Proteins 0.000 abstract 1
102000018674 Sodium Channels Human genes 0.000 abstract 1
208000005298 acute pain Diseases 0.000 abstract 1
230000036506 anxiety Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
206010015037 epilepsy Diseases 0.000 abstract 1
208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
201000006417 multiple sclerosis Diseases 0.000 abstract 1
208000004296 neuralgia Diseases 0.000 abstract 1
208000021722 neuropathic pain Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002691 topical anesthesia Methods 0.000 abstract 1
-1 triazole compounds Chemical class 0.000 abstract 1
208000009935 visceral pain Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20054775A 2003-03-18 2005-10-17 Biaryl-substituerte triazoler som natriumkanalblokkere NO20054775L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45595203P	2003-03-18	2003-03-18
PCT/US2004/007830 WO2004083190A1 (en)	2003-03-18	2004-03-12	Biaryl substituted triazoles as sodium channel blockers

Publications (2)

Publication Number	Publication Date
NO20054775D0 NO20054775D0 (no)	2005-10-17
NO20054775L true NO20054775L (no)	2005-12-16

Family

ID=33030073

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054775A NO20054775L (no)	2003-03-18	2005-10-17	Biaryl-substituerte triazoler som natriumkanalblokkere

Country Status (34)

Country	Link
US (2)	US7326726B2 (pl)
EP (1)	EP1606269B1 (pl)
JP (1)	JP4482554B2 (pl)
KR (1)	KR100737721B1 (pl)
CN (2)	CN1788002A (pl)
AR (1)	AR044503A1 (pl)
AT (1)	ATE412639T1 (pl)
AU (1)	AU2004221885C1 (pl)
BR (1)	BRPI0408407A (pl)
CA (1)	CA2519252C (pl)
CL (1)	CL2004000551A1 (pl)
CY (1)	CY1108720T1 (pl)
DE (1)	DE602004017438D1 (pl)
DK (1)	DK1606269T3 (pl)
EC (1)	ECSP056018A (pl)
EG (1)	EG25994A (pl)
ES (1)	ES2314387T3 (pl)
HR (1)	HRP20050816A2 (pl)
IS (1)	IS8001A (pl)
JO (1)	JO2480B1 (pl)
MA (1)	MA27665A1 (pl)
MX (1)	MXPA05009847A (pl)
MY (1)	MY142651A (pl)
NO (1)	NO20054775L (pl)
NZ (1)	NZ542205A (pl)
PE (1)	PE20041066A1 (pl)
PL (1)	PL1606269T3 (pl)
PT (1)	PT1606269E (pl)
RU (1)	RU2356897C2 (pl)
SI (1)	SI1606269T1 (pl)
TW (1)	TWI337605B (pl)
UA (1)	UA81660C2 (pl)
WO (2)	WO2004083190A1 (pl)
ZA (1)	ZA200506906B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2800237C (en)	2002-12-19	2016-05-17	The Scripps Research Institute	Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
MY142651A (en) *	2003-03-18	2010-12-15	Merck Sharp & Dohme	Biaryl substituted triazoles as sodium channel blockers
CN1922156A (zh) *	2003-11-10	2007-02-28	默克公司	作为钠通道阻断剂的取代的三唑
WO2005113523A1 (en)	2004-05-20	2005-12-01	Foldrx Pharmaceuticals, Inc.	2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
TW200728258A (en)	2005-10-10	2007-08-01	Glaxo Group Ltd	Novel compounds
EP1943216B1 (en)	2005-10-10	2010-06-30	Glaxo Group Limited	Prolinamide derivatives as sodium channel modulators
TW200730494A (en)	2005-10-10	2007-08-16	Glaxo Group Ltd	Novel compounds
EP2117538A1 (en)	2007-01-24	2009-11-18	Glaxo Group Limited	Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
PL2118077T3 (pl) *	2007-02-08	2015-05-29	Synta Pharmaceuticals Corp	Związki triazolowe modulujące aktywność hsp90
MX2009013332A (es)	2007-06-08	2010-01-25	Mannkind Corp	Inhibidores de ire-1 alfa.
ES2642586T3 (es)	2009-07-27	2017-11-16	Gilead Sciences, Inc.	Compuestos heterocíclicos condensados como moduladores de canales iónicos
EP2588197B1 (en)	2010-07-02	2014-11-05	Gilead Sciences, Inc.	Fused heterocyclic compounds as ion channel modulators
KR20140033377A (ko)	2011-05-10	2014-03-18	길리애드 사이언시즈, 인코포레이티드	나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
NO3175985T3 (pl)	2011-07-01	2018-04-28
UY34171A (es)	2011-07-01	2013-01-31	Gilead Sciences Inc	Compuestos heterocíclicos fusionados como moduladores del canal iónico
RU2586330C2 (ru)	2011-09-16	2016-06-10	Пфайзер Инк.	Твердые формы ингибитора диссоциации транстиретина
WO2013131018A1 (en) *	2012-03-02	2013-09-06	Zalicus Pharmaceuticals Ltd.	Biaryl inhibitors of the sodium channel
TWI568722B (zh)	2012-06-15	2017-02-01	葛蘭馬克製藥公司	作爲ｍＰＧＥＳ－１抑制劑之三唑酮化合物
JP6456909B2 (ja)	2013-03-15	2019-01-23	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Ｌｘｒ調節因子
ES2912881T3 (es)	2014-12-23	2022-05-30	Convergence Pharmaceuticals	Procedimiento para preparar derivados de alfa-carboxamida pirrolidina
JP6616244B2 (ja) *	2015-05-29	2019-12-04	北興化学工業株式会社	新規なヒドロキシフェニルボロン酸エステルとその製造方法、およびヒドロキシビフェニル化合物の製造法
US11192856B2 (en)	2017-10-05	2021-12-07	Biogen Inc.	Process for preparing alpha-carboxamide pyrrolidine derivatives
KR102512548B1 (ko)	2017-12-22	2023-03-22	삼성디스플레이 주식회사	유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
BR112020018403A2 (pt) *	2018-03-09	2020-12-22	Pi Industries Ltd.	Compostos heterocíclicoscomo fungicidas
CN108794413A (zh) *	2018-06-25	2018-11-13	青岛科技大学	一种1,2,4-三氮唑-3-甲酰胺的合成方法
CN108863965A (zh) *	2018-06-25	2018-11-23	青岛科技大学	一锅法制备1,2,4-三氮唑-3-甲酰胺的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US875782A (en) *	1907-04-29	1908-01-07	Walter H Cook	Fast-nut.
TW226993B (pl)	1992-05-29	1994-07-21	Kumiai Chemical Industry Co
US5455252A (en)	1993-03-31	1995-10-03	Syntex (U.S.A.) Inc.	Optionally substituted 6,8-quinolines
JP3682075B2 (ja) *	1993-04-16	2005-08-10	クミアイ化学工業株式会社	トリアゾール誘導体及び殺虫、殺ダニ剤
MY129541A (en) *	1996-06-25	2007-04-30	Novartis Ag	Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
IT1292091B1 (it) *	1997-06-05	1999-01-25	Geange Ltd	Derivati eterociclici aromatici azotati,procedimento per la loro preparazione e loro impiego come antigestativi,immunosoppressori e
GB9726987D0 (en)	1997-12-22	1998-02-18	Glaxo Group Ltd	Compounds
TW502019B (en) *	1999-03-26	2002-09-11	Cocensys Inc	Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
AR029489A1 (es)	2000-03-10	2003-07-02	Euro Celtique Sa	Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
CA2445568A1 (en) *	2001-04-27	2002-11-07	Vertex Pharmaceuticals Incorporated	Triazole-derived kinase inhibitors and uses thereof
US6797722B2 (en) *	2002-05-03	2004-09-28	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
BR0312503A (pt) *	2002-07-09	2007-06-26	Bristol Myers Squibb Co	derivados heterocìclicos substituìdos úteis como agentes antidiabéticos e antiobesidade, composição farmacêutica, uso e combinação dos mesmos
KR100467668B1 (ko) *	2002-08-07	2005-01-24	씨제이 주식회사	1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100470075B1 (ko) *	2002-11-21	2005-02-05	씨제이 주식회사	1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
JO2397B1 (en) *	2002-12-20	2007-06-17	ميرك شارب اند دوم كوربوريشن	Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
MY142651A (en) *	2003-03-18	2010-12-15	Merck Sharp & Dohme	Biaryl substituted triazoles as sodium channel blockers
CN1922156A (zh) *	2003-11-10	2007-02-28	默克公司	作为钠通道阻断剂的取代的三唑

2004
- 2004-03-11 MY MYPI20040842A patent/MY142651A/en unknown
- 2004-03-11 AR ARP040100789A patent/AR044503A1/es unknown
- 2004-03-12 BR BRPI0408407-1A patent/BRPI0408407A/pt not_active IP Right Cessation
- 2004-03-12 UA UAA200509759A patent/UA81660C2/ru unknown
- 2004-03-12 US US10/799,230 patent/US7326726B2/en not_active Expired - Lifetime
- 2004-03-12 ES ES04720360T patent/ES2314387T3/es not_active Expired - Lifetime
- 2004-03-12 PL PL04720360T patent/PL1606269T3/pl unknown
- 2004-03-12 CN CNA200480013089XA patent/CN1788002A/zh active Pending
- 2004-03-12 EP EP04720360A patent/EP1606269B1/en not_active Expired - Lifetime
- 2004-03-12 JP JP2006507122A patent/JP4482554B2/ja not_active Expired - Fee Related
- 2004-03-12 DK DK04720360T patent/DK1606269T3/da active
- 2004-03-12 SI SI200430959T patent/SI1606269T1/sl unknown
- 2004-03-12 NZ NZ542205A patent/NZ542205A/en not_active IP Right Cessation
- 2004-03-12 AT AT04720360T patent/ATE412639T1/de active
- 2004-03-12 HR HR20050816A patent/HRP20050816A2/hr not_active Application Discontinuation
- 2004-03-12 RU RU2005132168/04A patent/RU2356897C2/ru not_active IP Right Cessation
- 2004-03-12 CN CNA2008101000997A patent/CN101289428A/zh active Pending
- 2004-03-12 PT PT04720360T patent/PT1606269E/pt unknown
- 2004-03-12 WO PCT/US2004/007830 patent/WO2004083190A1/en not_active Ceased
- 2004-03-12 KR KR1020057017327A patent/KR100737721B1/ko not_active Expired - Fee Related
- 2004-03-12 DE DE602004017438T patent/DE602004017438D1/de not_active Expired - Lifetime
- 2004-03-12 CA CA002519252A patent/CA2519252C/en not_active Expired - Fee Related
- 2004-03-12 WO PCT/US2004/007597 patent/WO2004083189A1/en not_active Ceased
- 2004-03-12 MX MXPA05009847A patent/MXPA05009847A/es active IP Right Grant
- 2004-03-12 AU AU2004221885A patent/AU2004221885C1/en not_active Ceased
- 2004-03-14 JO JO200430A patent/JO2480B1/en active
- 2004-03-16 PE PE2004000280A patent/PE20041066A1/es not_active Application Discontinuation
- 2004-03-17 TW TW093107083A patent/TWI337605B/zh not_active IP Right Cessation
- 2004-03-17 CL CL200400551A patent/CL2004000551A1/es unknown
2005
- 2005-08-29 IS IS8001A patent/IS8001A/is unknown
- 2005-08-29 ZA ZA200506906A patent/ZA200506906B/xx unknown
- 2005-09-06 MA MA28481A patent/MA27665A1/fr unknown
- 2005-09-14 EC EC2005006018A patent/ECSP056018A/es unknown
- 2005-09-18 EG EGNA2005000548 patent/EG25994A/xx active
- 2005-10-17 NO NO20054775A patent/NO20054775L/no not_active Application Discontinuation
2008
- 2008-01-30 US US12/011,967 patent/US7572822B2/en not_active Expired - Lifetime
2009
- 2009-01-15 CY CY20091100054T patent/CY1108720T1/el unknown

Also Published As

Publication number	Publication date
KR20050109583A (ko)	2005-11-21
HRP20050816A2 (hr)	2006-04-30
SI1606269T1 (sl)	2009-02-28
PE20041066A1 (es)	2005-01-22
US20080171777A1 (en)	2008-07-17
UA81660C2 (ru)	2008-01-25
MXPA05009847A (es)	2005-12-05
US7326726B2 (en)	2008-02-05
EG25994A (en)	2012-11-28
CA2519252A1 (en)	2004-09-30
NZ542205A (en)	2008-11-28
ZA200506906B (en)	2007-02-28
MA27665A1 (fr)	2005-12-01
MY142651A (en)	2010-12-15
US20050119261A1 (en)	2005-06-02
TW200505876A (en)	2005-02-16
AR044503A1 (es)	2005-09-14
EP1606269A1 (en)	2005-12-21
CN101289428A (zh)	2008-10-22
ATE412639T1 (de)	2008-11-15
CY1108720T1 (el)	2013-09-04
JO2480B1 (en)	2009-01-20
RU2005132168A (ru)	2006-04-27
JP4482554B2 (ja)	2010-06-16
JP2006520782A (ja)	2006-09-14
WO2004083190A1 (en)	2004-09-30
DK1606269T3 (da)	2009-02-09
PL1606269T3 (pl)	2009-04-30
AU2004221885C1 (en)	2010-09-23
TWI337605B (en)	2011-02-21
PT1606269E (pt)	2008-12-16
CN1788002A (zh)	2006-06-14
ECSP056018A (es)	2006-01-27
DE602004017438D1 (de)	2008-12-11
CA2519252C (en)	2008-11-18
ES2314387T3 (es)	2009-03-16
KR100737721B1 (ko)	2007-07-11
NO20054775D0 (no)	2005-10-17
AU2004221885B2 (en)	2010-04-22
BRPI0408407A (pt)	2006-03-21
CL2004000551A1 (es)	2005-01-21
RU2356897C2 (ru)	2009-05-27
IS8001A (is)	2005-08-29
AU2004221885A1 (en)	2004-09-30
WO2004083189A1 (en)	2004-09-30
US7572822B2 (en)	2009-08-11
EP1606269B1 (en)	2008-10-29

Legal Events

Date	Code	Title	Description
2013-11-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20054775L (no)	2005-12-16	Biaryl-substituerte triazoler som natriumkanalblokkere
NO20091620L (no)	2009-07-09	Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser
WO2007112345A3 (en)	2007-11-29	Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
WO2007145922A3 (en)	2008-08-21	Benzazepinones as sodium channel blockers
WO2005047270A3 (en)	2005-09-22	Substituted triazoles as sodium channel blockers
WO2011027249A3 (en)	2011-09-01	Benzimidazole derivatives
WO2007112357A3 (en)	2007-12-27	Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
WO2009066041A3 (fr)	2009-12-17	Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2010095768A8 (en)	2011-08-04	4 -isopropylphenyl glucitol compounds as sglt1 inhibitors
IL181095A0 (en)	2007-07-04	Polysulfated glycosides and salts thereof
EA201001094A1 (ru)	2011-04-29	Производные индазола
WO2007075524A3 (en)	2008-11-20	Substituted piperidines as calcium channel blockers
MX2022009967A (es)	2022-10-21	Compuestos para el tratamiento de la infeccion por coronavirus.
NO20001169L (no)	2000-04-05	6,9-bro erythromycinderivater
BR0311136A (pt)	2007-04-27	composto ou um sal, enanciÈmero, diaestereÈmero ou éster hidrolisável in vivo ou mistura dos mesmos farmaceuticamente aceitável, composição, e, método para inibir a atividade de fator letal (lf) liberado de bactérias em um mamìfero
TNSN05246A1 (en)	2007-06-11	Use of 10-hydroxy-10, 11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2001014358A3 (en)	2001-05-17	Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
WO2010045582A3 (en)	2010-07-29	Compositions and methods for treating or preventing hypoxic or ischemic injury
WO2005037213A3 (en)	2006-07-13	Antiinflammatory inhibitors of respiratory burst in adherent neutrophils
MX2023004435A (es)	2023-05-08	Compuestos y composiciones para el tratamiento de la criptosporidiosis.
JP2008531613A5 (pl)	2009-04-02
WO2007084394A3 (en)	2008-01-24	2,5 diaza-bicyclo[2.2.1]heptane derivatives as calcium channel blockers
WO2024239001A3 (en)	2025-03-06	Isoandrographolide analogs and method for treatment using the same
GEP20135858B (en)	2013-06-25	Compound with serotoninergic activity, method of its preparation, and pharmaceutical composition containing thereof
SE0201881D0 (sv)	2002-06-19	Novel compounds, their use, and preparation